Biotech stories
BC celebrates tech innovation with 2025 TIA awards
Last week
#
biotech
The 2025 Technology Impact Awards in Vancouver celebrated BC's tech innovation, spotlighting CAD $3bn deals and Clio's Deal of the Year win.
Nebius raises USD $4.3 billion to boost AI & Asia expansion
Last month
#
biotech
Nebius Group has raised USD $4.3 billion to enhance its AI infrastructure and support expansion into Asia, focusing on biotech and drug discovery.
Hyderabad hosts IMECE India 2025 to drive innovation & growth
Thu, 18th Sep 2025
#
biotech
IMECE India 2025 in Hyderabad united engineers, policymakers, and academics to boost innovation, sustainability, and growth in India's manufacturing and technology sectors.
Biostate AI’s K-Dense accelerates scientific research cycles with AI
Thu, 18th Sep 2025
#
biotech
Biostate AI’s K-Dense Beta, an AI research system, slashes biological research times from years to weeks, proven through Harvard Medical School longevity studies.
A defining moment is approaching for Australian manufacturing
Tue, 19th Aug 2025
#
biotech
Australia's manufacturing faces a pivotal moment; ARM Hub's CEO urges rapid SME adoption of automation to boost competitiveness and innovation.
Predictive risk scores: The future of AI in disease prevention and diagnosis
Sat, 26th Jul 2025
#
biotech
AI-powered predictive risk scores are revolutionising disease prevention by enabling early detection and personalised health interventions before symptoms arise.
Swiss Deep Tech startups surpass USD $100 billion in value
Fri, 27th Jun 2025
#
biotech
Swiss Deep Tech startups have surpassed USD $100 billion in value, boosted by strong venture capital and academic innovation in AI, biotech, and space sectors.
Superlab Suisse to open new lab at Campus Biotech Geneva
Thu, 19th Jun 2025
#
biotech
Superlab Suisse will open its fourth Swiss lab at Geneva’s Campus Biotech by January 2026, offering flexible space for biotech startups in the growing life sciences hub.
Kyron.bio raises EUR €5.5m to boost safer antibody therapies
Thu, 29th May 2025
#
biotech
Paris-based kyron.bio has raised EUR
5.5m to advance glycan-engineering tech, aiming to improve safety and efficacy of antibody therapies for cancer and autoimmune diseases.
Auckland unveils alliance to unite & grow city technology sector
Tue, 20th May 2025
#
biotech
Auckland Mayor unveils Innovation & Technology Alliance to boost collaboration, tech growth, and economic productivity in the city and region.
OpenText powers BMO & Catalent digital transformation with AI
Fri, 18th Apr 2025
#
biotech
OpenText is enhancing information management through AI and cloud solutions in partnerships with BMO and Catalent Pharma to boost compliance and efficiency.
Nebius to expand AI cloud operations, Singapore eyed as hub
Thu, 17th Apr 2025
#
biotech
Nebius is expanding its AI infrastructure into Southeast Asia, choosing Singapore as a hub to boost regional AI adoption and startup support.
Atturra acquires Kitepipe in USD $3.15 million deal
Mon, 10th Mar 2025
#
biotech
Atturra has secured the acquisition of Project Delivery Services LLC, known as Kitepipe, for USD $3.15 million, enhancing its Boomi service capabilities.
UK tech firms eyeing growth in South Korean AI sectors
Fri, 7th Mar 2025
#
biotech
The UK-APAC Tech Growth Programme has successfully arranged over 40 meetings for six UK tech firms with leading South Korean businesses, promoting semiconductor and AI innovations.
Shaping the future: Women leading the AI revolution on International Women's Day
Thu, 6th Mar 2025
#
biotech
On International Women's Day, women pioneers in AI are reshaping tech, championing diverse perspectives to ensure technology serves all of humanity.
Fuse Vectors secures USD $5.2m for gene therapy tech
Wed, 26th Feb 2025
#
biotech
Danish biotech firm Fuse Vectors has secured USD $5.2 million in pre-seed funding to advance its innovative cell-free gene therapy technology.
Iktos & Cube Biotech partner to tackle metabolic disorders
Tue, 14th Jan 2025
#
biotech
Iktos and Cube Biotech have partnered to leverage AI-driven drug discovery and advanced protein technology, targeting the Amylin Receptor for cardiometabolic disorders.
New Relic named a Leader in Gartner 2024 Magic Quadrant
Mon, 28th Oct 2024
#
biotech
New Relic has been named a Leader in the 2024 Gartner Magic Quadrant for Digital Experience Monitoring, praised for its visionary integrations and customer satisfaction.
Hexaware, PointCross partner on clinical data automation solution
Wed, 2nd Oct 2024
#
biotech
Hexaware Technologies and PointCross Life Sciences have launched a Clinical Data Automation solution to streamline data management for the BioPharma and BioTech sectors.
Redalpine closes largest fund at USD $200m, opens London office
Thu, 29th Aug 2024
#
biotech
Redalpine closes its largest fund to date, the USD $200 million RAC VII, bringing total assets to over USD $1 billion and opens a new office in London.